Addressing acute coronary syndromes: New challenges and opportunities after the CANTOS trial (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study)

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)1100-1102
Number of pages3
JournalCirculation
Volume137
Issue number11
DOIs
Publication statusPublished - Jan 1 2018

Keywords

  • Acute coronary syndrome
  • Biomarkers
  • Immune system
  • Immunomodulation
  • Physiopathology
  • Precision medicine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this